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 Life expectancy for older people in Ireland has been increasing steadily 
since the 1980s. Despite this, Irish life expectancies for the over 65s lagged 
seriously behind the EU average as recently as the mid 1990s. But Irish 
death rates for the over 65s dropped dramatically between 2000 and 2005, 
moving Ireland closer to the European average. Whereas between 1996 and 
1999 death rates (from all causes) in Ireland had fallen by just over 5%, 
between 2000 and 2004 the decrease was over 26%. What lies behind this 
rare and welcome good news story? An article** by researchers from the 
ESRI and the Department of Pharmacology and Therapeutics at Trinity 
College Dublin sets out the background to this sharp fall in death rates, and  
examines how the greater use of effective drug therapies contributed to this 
result. 
 
The fall in mortality was particularly pronounced for diseases of the 
circulatory system such as heart disease and strokes where there was a 30% 
reduction between 2000 and 2005. This was an extraordinary development 
that, if sustained, had huge implications for the provision of services to 
older Irish people such as pensions and health care. Looking around for 
clues some noticed that the fall in the rate of deaths was particularly 
pronounced in the winter months (See Figure 1). Ireland sees 21% more 
deaths in the depths of winter than in high summer (almost twice the 
Danish proportion), largely from the interaction of low temperature with 
existing cardiovascular and respiratory conditions so analysts initially 
looked to global warming for an explanation. Analysis of weather trends 
showed no warming during recent winters so what could explain the drop 
in death rates? 
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 Figure 1: Deaths from Circulatory Diseases In Ireland Per 1000 
People Aged 65+
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One possible explanation may lie in changing prescribing patterns in 
Ireland. Since 1995 there has been a steady year on year increase in the 
number of items prescribed but around the turn of the century, the rate of 
prescribing increased significantly. Between 1995 and 1999 the number of 
items per patient increased by 26% whereas between 2000 and 2004 the 
increase was 53%. Doctors also appeared to be prescribing more expensive 
medicines after 1999. The average cost per item increased by 64% between 
1995 and 1999 compared to 122% 2000-2005 even though pharmaceutical 
inflation had been negligible. The increasing volume and cost of 
pharmaceuticals prescribed meant steeply increasing HSE expenditures on 
pharmaceuticals after 2000 (see Figure 2). A large part of this increase in 
items and expenditure was due to the increased prescribing of 
cardiovascular medicines. These had been increasing since the late 1990s 
following the Irish Cardiovascular Strategy but rates of prescribing grew 
quickly following the introduction of the medical card for over 70s in the 
July of 2001 and the subsequent increase in use of primary care by older 
people (see Layte et al 2009). Between 1999 and 2003 the volume of ace 
inhibitors prescribed almost doubled, the volume of beta blockers more 
than doubled, while the volume of statins prescribed more than trebled.   
 
 
 Figure 2: HSE Expenditure on Pharmaceuticals 1997-2005 
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Could this change in prescribing explain the sudden fall in mortality 
among older Irish people? The timing of the change in prescribing seems 
plausible and it is known that drugs such as beta blockers and ace inhibitors 
can counteract some of the strains placed on the cardiovascular system by 
cold weather.  
 
Using data on patterns of mortality across age and sex groups and 
prescribing patterns by year and quarter between 1995 and 2005 the 
researchers showed that there was indeed a change, or ‘structural break’ in 
the pattern of mortality in Ireland around the turn of the century. After 
1999 for instance, excess winter mortality fell by 9% among Irish men and 
6.8% among Irish women. Further analysis showed that this change could 
be explained by increased prescribing of beta blockers, ace inhibitors and 
aspirin medications.  
 
Such falls in mortality are a cause for celebration and mean thousands of 
people are alive today who would otherwise have died. It is likely that these 
cardiovascular medications are also contributing to the significant decrease 
in disability among older Irish people experienced in recent years. The 
effect also underlines the important role played by primary care in the Irish 
health care system. As well as keeping many people alive, this prescribing 
also prevented many older Irish people from experiencing the heart attacks 
and strokes that would have otherwise occurred and in so doing, saved the 
Irish hospital system a great deal of resources. This is a good example of 
the importance of treatment protocols since some of the change is 
attributable to the cardiovascular strategy and secondary prevention. 
However, the change in prescribing was most marked after the change in 
eligibility for the medical card. This shows the benefits that accrue from 
providing primary care free at the point of delivery and keeping prescribing 
fees modest. Early use of primary care prevents more serious illness later 
and helps to move healthcare from expensive public hospitals to relatively 
less expensive primary care settings. This research also suggests that taking 
medical cards from some over 70s and the recent introduction of the 50c 
prescribing fee may impact on health and mortality in Ireland. Drug 
budgets have increased strongly in recent years and there are good grounds 
to believe that we can and should reduce prescribing expenditure. In doing 
so we should not lose sight of the fact that medical treatments both save 
 
  
lives and help people live productive lives with chronic illnesses that would 
have been profoundly disabling two decades ago.  
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